Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The cytoskeleton meets the skeleton. Focus on "Deficiency of the intermediate filament synemin reduces bone mass in vivo".

Literature DB >> 27784680

The cytoskeleton meets the skeleton. Focus on "Deficiency of the intermediate filament synemin reduces bone mass in vivo".

Omar Skalli¹.

Abstract

Mesh：

Substances：

Year: 2016 PMID： 27784680 PMCID： PMC5206306 DOI： 10.1152/ajpcell.00303.2016

Source DB: PubMed Journal: Am J Physiol Cell Physiol ISSN： 0363-6143 Impact factor: 4.249

× No keyword cloud information.

11 in total

1. Myopathic changes in murine skeletal muscle lacking synemin.

Authors: Karla P García-Pelagio; Joaquin Muriel; Andrea O'Neill; Patrick F Desmond; Richard M Lovering; Linda Lund; Meredith Bond; Robert J Bloch
Journal: Am J Physiol Cell Physiol Date: 2015-01-07 Impact factor: 4.249

2. Expression of the Hutchinson-Gilford progeria mutation during osteoblast development results in loss of osteocytes, irregular mineralization, and poor biomechanical properties.

Authors: Eva Schmidt; Ola Nilsson; Antti Koskela; Juha Tuukkanen; Claes Ohlsson; Björn Rozell; Maria Eriksson
Journal: J Biol Chem Date: 2012-08-14 Impact factor: 5.157

Review 3. Vimentin: the conundrum of the intermediate filament gene family.

Authors: R M Evans
Journal: Bioessays Date: 1998-01 Impact factor: 4.345

4. The intermediate filament vimentin regulates chondrogenesis of adult human bone marrow-derived multipotent progenitor cells.

Authors: Brent E Bobick; Rocky S Tuan; Faye H Chen
Journal: J Cell Biochem Date: 2010-01-01 Impact factor: 4.429

5. Synemin acts as a regulator of signalling molecules during skeletal muscle hypertrophy.

Authors: Zhenlin Li; Ara Parlakian; Dario Coletti; Sonia Alonso-Martin; Christophe Hourdé; Pierre Joanne; Jacqueline Gao-Li; Jocelyne Blanc; Arnaud Ferry; Denise Paulin; Zhigang Xue; Onnik Agbulut
Journal: J Cell Sci Date: 2014-09-01 Impact factor: 5.285

6. Synemin: Molecular Features and the Use of Proximity Ligation Assay to Study Its Interactions.

Authors: Madhumita Paul; Omar Skalli
Journal: Methods Enzymol Date: 2015-11-26 Impact factor: 1.600

7. Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.

Authors: Na Lian; Tonghui Lin; Wenguang Liu; Weiguang Wang; Lingzhen Li; Stephanie Sun; Jeffry S Nyman; Xiangli Yang
Journal: J Biol Chem Date: 2012-09-04 Impact factor: 5.157

The cytoskeleton meets the skeleton. Focus on "Deficiency of the intermediate filament synemin reduces bone mass in vivo".

1. Myopathic changes in murine skeletal muscle lacking synemin.

2. Expression of the Hutchinson-Gilford progeria mutation during osteoblast development results in loss of osteocytes, irregular mineralization, and poor biomechanical properties.

Review 3. Vimentin: the conundrum of the intermediate filament gene family.

4. The intermediate filament vimentin regulates chondrogenesis of adult human bone marrow-derived multipotent progenitor cells.

5. Synemin acts as a regulator of signalling molecules during skeletal muscle hypertrophy.

6. Synemin: Molecular Features and the Use of Proximity Ligation Assay to Study Its Interactions.

7. Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.

8. Synemin promotes AKT-dependent glioblastoma cell proliferation by antagonizing PP2A.

9. Deficiency of the intermediate filament synemin reduces bone mass in vivo.

10. Decreased bone formation and osteopenia in lamin a/c-deficient mice.

1. Deficiency of the intermediate filament synemin reduces bone mass in vivo.